Epidemiological Analysis of Primary Hepatocellular Carcinoma Death and Its Mechanism of Promoting Cancer

DOI: https://doi.org/10.62517/jmhs.202405217

Author(s)

Sitong Lin

Affiliation(s)

Division of Biosciences, University College London, Gower Street, London WC1E 6BT, UK

Abstract

Primary liver cancer (PLC) is the sixth most common cancer globally and the third leading cause of cancer-related deaths worldwide, ranking as the second leading cause of cancer deaths in China. Hepatocellular carcinoma (HCC) is the main histological type of PLC. Globally, 56% of PLC cases are due to Hepatitis B virus (HBV) infection, while 20% are due to Hepatitis C virus (HCV) infection. Chronic HBV infection is the main cause of PLC in East Asian countries including China, whereas HCV infection and non-alcoholic fatty liver disease are the main causes in most Western countries. This article analyzes the epidemiology of primary liver cancer deaths both domestically and internationally, as well as the impact of HBV infection on the survival of HCC patients, discussing the significant role of HBV infection in HCC. It explores the specific mechanisms through which HBV infection regulates TERT transcription via HBV-TERT integration, impacting the progression of HCC, and provides insights for clinical research on liver cancer.

Keywords

Liver Cancer; Epidemiology; Carcinogenesis Mechanisms

References

[1] Chen Qianqian, Rui Fajuan, Ni Wenjing, et al. Research progress of epidemiology and risk factors of primary liver cancer [J]. Chinese Journal of General Medicine, 2024, 27(06):637-642. [2] Hao Yun, Li Chuan, Wen Tianfu, et al. Epidemiological characteristics of liver cancer in the world and China: an interpretation report based on the 2022 Global Cancer Statistics Report [J/OL]. Chinese Journal of Basic and Clinical Studies, 2024:1-10. [3] Ren DDAN. Epidemiological analysis of primary liver cancer and clinical characteristics of HBV-related liver cancer in Yan 'an area [D]. Yan 'an University,2022. [4] Lin J S. Epidemiological and clinical characteristics and preoperative parameters of primary liver cancer from 2003 to 2020 to predict the prognosis of hepatocellular carcinoma [D]. Jinan University,2022. [5] Xie BH, Oncogene-driven metastasis mechanism of liver cancer. The First Affiliated Hospital of Gannan Medical College, Jiangxi Province,2022, China. [6] Zhang Qianyi, Guo Jimin, Xue Jiarui, et al. Analysis of co-promoting mechanism of BAZ1A in hepatocellular carcinoma and cervical carcinoma [J]. Chinese Journal of Health Standards Management, 2024, 15(08):173-177.